'Toxic' oestrogen by-product linked with fatal lung condition

August 6, 2012

(Medical Xpress) -- The breakdown of oestrogen could play an important role in the onset of a rare but devastating condition of high blood pressure in the lungs.

In a study funded by the British Heart Foundation (BHF) and published in journal Circulation, scientists from the University of Glasgow showed that high levels of an enzyme in the lungs called CYP1B1 – which breaks down oestrogen into harmful smaller molecules – could play a role in the development of pulmonary arterial hypertension.

Around 3,000 people in the UK have pulmonary arterial hypertension, when overactive cell growth in blood vessel walls reduces the space for blood flow in the lungs. Often affecting younger, pre-menopausal women, symptoms include breathlessness and chest pain. The signs worsen as lung blood pressure increases, and the disorder is often fatal. More than one in ten patients die within the first year of diagnosis.

Although there are treatments available, they are often not effective.

This new study shows a link between high levels of a harmful molecule produced from the breakdown of oestrogen by CYP1B1 and the development of pulmonary arterial hypertension. The findings could help lead to new treatments to tackle the disease.

The researchers showed that CYP1B1 levels were elevated in the lungs of mice with pulmonary arterial hypertension, and that lowering CYP1B1 levels reduced the severity of the disease. A ‘toxic’ by-product of oestrogen – called 16α-hydroxyestrone – was found in elevated amounts in the urine of mice that did develop the condition.

Importantly, the researchers also examined a small number of lung samples from human patients with pulmonary hypertension – all of whom had elevated levels of CYP1B1. This means that targeting the enzyme with a specific drug in the future might make a difference for patients.

Professor Mandy MacLean, Professor of Pulmonary Pharmacology at the University of Glasgow’s Institute of Cardiovascular and Medical Sciences, who leads a BHF programme grant, said: “Pulmonary arterial hypertension is a really debilitating disease, often fatal, that we need to do more to understand.

“We found that its onset seems to have a lot to do with raised levels of toxic molecules in the lungs, produced from the breakdown of oestrogen by a regulatory protein that’s gone out of control.

“We think it’s an important discovery because drugs that target this protein – called CYP1B1 – already exist, so our discovery provides a real rationale to go on to test these drugs in human patients.”

Dr Shannon Amoils, Research Advisor at the BHF, which co-funded the research, said: “ is more common in women, which has led to the suggestion that the higher oestrogen levels found in women might be linked to higher risk. Up till now, though, studies in animal models haven’t come up with a clear answer.

“This interesting study in mice, which also looked at human samples, shows that abnormal oestrogen breakdown in the lungs may be an important factor. But many questions about this condition are still unanswered, and the next stage is to move on to examine this association more closely in patients.”

Explore further: Potential new approach to treatment of chronic lung diseases

Related Stories

Potential new approach to treatment of chronic lung diseases

March 26, 2012
(Medical Xpress) -- Scientists at UCD have identified a potential new treatment for life-threatening complications associated with chronic obstructive lung diseases like emphysema and chronic bronchitis. Chronic obstructive ...

Researchers move closer to a cure for a deadly cardiovascular disease

June 24, 2011
(Medical Xpress) -- A multidisciplinary research team in the Faculty of Medicine & Dentistry at the University of Alberta has taken a big step towards understanding the cause and potential cure for a deadly cardiovascular ...

Recommended for you

Study of what makes cells resistant to radiation could improve cancer treatments

October 18, 2017
A Johns Hopkins University biologist is part of a research team that has demonstrated a way to size up a cell's resistance to radiation, a step that could eventually help improve cancer treatments.

New approach helps rodents with spinal cord injury breathe on their own

October 17, 2017
One of the most severe consequences of spinal cord injury in the neck is losing the ability to control the diaphragm and breathe on one's own. Now, investigators show for the first time in laboratory models that two different ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

New method to measure how drugs interact

October 17, 2017
Cancer, HIV and tuberculosis are among the many serious diseases that are frequently treated with combinations of three or more drugs, over months or even years. Developing the most effective therapies for such diseases requires ...

A new compound targets energy generation, thereby killing metastatic cells

October 17, 2017
Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread, from the primary tumor throughout the patient's body. Although immunotherapy ...

Research finds that zinc binding is vital for regulating pH levels in the brain

October 17, 2017
Researchers in Oslo, Norway, have discovered that zinc binding plays an important role in the sensing and regulation of pH in the human brain. The findings come as one of the first studies that directly link zinc binding ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.